Abstract
Combined chemotherapy with 5-FU and BCNU was compared with placebo in a triple-blind, randomized study of 40 patients with pancreatic adenocarcinoma. There were no significant differences between the groups with regard to survival, tumor size, or quality of life.
Key-words: